A retrospective study analysing effect of rivaroxaban as thromboprophylaxis in patients with lower limb cast immobilisation
Latest Information Update: 23 Mar 2021
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- 23 Mar 2021 New trial record
- 01 Feb 2021 Primary endpoint has been met. (incidence of clinically symptomatic thromboembolic events (DVT and or PE), as per results published in the Irish Journal of Medical Science
- 01 Feb 2021 Results published in the Irish Journal of Medical Science